Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal basal ganglia morphology (HP:0002134)help
Parent Node:
expand
Abnormal basal ganglia MRI signal intensity (HP:0012751)help
..Starting node
..expand
Focal T2 hyperintense basal ganglia lesion (HP:0007183)help
Term ID: 7183
Name: Focal T2 hyperintense basal ganglia lesion
Synonym: Hyperintense lesions in the basal ganglia on MRI
Definition: A lighter than expected T2 signal on magnetic resonance imaging (MRI) of the basal ganglia. This term refers to a localized hyperintensity affecting a particular region of the basal ganglia.
Comments:
Reference: HP:0007183
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandFocal T2 hypointense basal ganglia lesion (HP:0012752) help
..expandT2 hypointense basal ganglia (HP:0012753) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ALG2 CL E G H8536523159OMIM:607906Congenital disorder of glycosylation, type Ii46
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ATP6 CL E G H45087414ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0COQ2 CL E G H2723525223ORPHA:255249Leigh syndrome with nephrotic syndromeHP:0040282 - Frequent54
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0COX15 CL E G H13552263ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent104
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ECHS1 CL E G H18923151ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent33
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ETHE1 CL E G H2347423287OMIM:602473Encephalopathy, ethylmalonic.42
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0FOXRED1 CL E G H5557226927ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent61
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0GFAP CL E G H26704235ORPHA:363717Alexander disease type I188
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0LIPT1 CL E G H5160129569ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent21
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0LRPPRC CL E G H1012815714ORPHA:70472Congenital lactic acidosis, Saguenay-Lac-Saint-Jean typeHP:0040282 - Frequent191
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0MECR CL E G H5110219691ORPHA:508093MEPAN syndrome6
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0MTFMT CL E G H12326329666ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent29
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ND1 CL E G H45357455ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ND2 CL E G H45367456ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ND3 CL E G H45377458ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ND4 CL E G H45387459ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ND5 CL E G H45407461ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0ND6 CL E G H45417462ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFA10 CL E G H47057684ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent91
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFA12 CL E G H5596723987ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent7
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFA13 CL E G H5107917194ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent3
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFA2 CL E G H46957685ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent19
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFA4 CL E G H46977687ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent4
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFA9 CL E G H47047693ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent27
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFAF2 CL E G H9194228086ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent26
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFAF5 CL E G H7913315899ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent34
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFAF6 CL E G H13768228625ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent39
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS1 CL E G H47197707ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent81
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS2 CL E G H47207708ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent65
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS3 CL E G H47227710ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent22
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS4 CL E G H47247711ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent27
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS7 CL E G H3742917714ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent38
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFS8 CL E G H47287715ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent42
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFV1 CL E G H47237716ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent74
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0NDUFV2 CL E G H47297717ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent27
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0PDE10A CL E G H108468772ORPHA:494541Childhood-onset benign chorea with striatal involvement5
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0PDHA1 CL E G H51608806ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent88
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0PDSS2 CL E G H5710723041ORPHA:255249Leigh syndrome with nephrotic syndromeHP:0040282 - Frequent54
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0PET100 CL E G H10013180140038ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent6
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0PRNP CL E G H56219449ORPHA:282166Inherited Creutzfeldt-Jakob diseaseHP:0040282 - Frequent69
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0SDHA CL E G H638910680ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent304
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0SLC19A3 CL E G H8070416266ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent110
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0SPG11 CL E G H8020811226ORPHA:2822Autosomal recessive spastic paraplegia type 11HP:0040283 - Occasional287
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0SUCLG1 CL E G H880211449OMIM:245400Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)60
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0SURF1 CL E G H683411474ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent73
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0TACO1 CL E G H5120424316ORPHA:255241Leigh syndrome with leukodystrophyHP:0040281 - Very frequent23
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0TACO1 CL E G H5120424316OMIM:619052MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8; MC4DN823
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0TRNK CL E G H45667489ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0TRNL1 CL E G H45677490ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0TRNV CL E G H45777500ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0007183Focal T2 hyperintense basal ganglia lesion0TRNW CL E G H45787501ORPHA:255210Mitochondrial DNA-associated Leigh syndromeHP:0040282 - Frequent
HP:0007183HP:0031206Striatal T2 hyperintensity1MECR CL E G H5110219691ORPHA:508093MEPAN syndrome6
HP:0007183HP:0031206Striatal T2 hyperintensity1PDE10A CL E G H108468772ORPHA:494541Childhood-onset benign chorea with striatal involvementHP:0040282 - Frequent5


Genes (50) :ALG2 ATP6 COQ2 COX15 ECHS1 ETHE1 FOXRED1 GFAP LIPT1 LRPPRC MECR MTFMT ND1 ND2 ND3 ND4 ND5 ND6 NDUFA10 NDUFA12 NDUFA13 NDUFA2 NDUFA4 NDUFA9 NDUFAF2 NDUFAF5 NDUFAF6 NDUFS1 NDUFS2 NDUFS3 NDUFS4 NDUFS7 NDUFS8 NDUFV1 NDUFV2 PDE10A PDHA1 PDSS2 PET100 PRNP SDHA SLC19A3 SPG11 SUCLG1 SURF1 TACO1 TRNK TRNL1 TRNV TRNW

Diseases (14) :OMIM:607906 ORPHA:255210 ORPHA:255249 ORPHA:255241 OMIM:602473 ORPHA:363717 ORPHA:70472 ORPHA:508093 OMIM:252010 ORPHA:494541 ORPHA:282166 ORPHA:2822 OMIM:245400 OMIM:619052
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.